clene(clnn)“買入”評級:
描述::Clene(CLNN):
Clene(CLNN) 8-K Current report, items 1.01 and 9.01 Accession Number: 0000950170-22-026770 Act: 34 Size: 362 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-022334 Act: 34 Size: 798 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007530 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0000950170-22-026772 Act: 33 Size: 104 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007507 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 8-K Current report, items 1.01, 2.03, 8.01, and 9.01 Accession Number: 0000950170-22-026482 Act: 34 Size: 672 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007458 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007506 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007504 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007509 Size: 5 KB 網頁鏈接
Clene(CLNN):
智通財經APP獲悉,H.C. Wainwright分析師Joseph Pantginis重申了對Clene(CLNN.US)“買入”評級,目標價為15美元。此前該公司的鋅銀離子溶液CNM-ZnAg未能達到新冠肺炎的第二階段主要終點。Pantginis在一份研究報告中告訴投資者,雖然CNM-... 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007503 Size: 5 KB 網頁鏈接
BT財經:
【BT機構股評】Clene決定停止對新冠肺炎的研究
H.C.Wainwright分析師Joseph Pantginis近日表示,重申對生物制藥公司Clene的“買入”評級,并給出目標價15美元。分析師指出,此前Clene公司的CNM-ZnAg未能達到新冠肺炎的第二階段主要終點。雖然CNM-ZnAg無法在具有多種SARS-CoV-2變體的異質人群中緩解新冠肺炎癥狀,但觀察到的良好的安全性或可以支持其用于治療其他病毒和細菌感染。但Clene決定停止未來對新冠肺炎的研究,而其納米療法CNM-Au8仍然是該公司治療多種神經退行性疾病的主要成果。#Clene#Clene(CLNN)
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007457 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007508 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007627 Size: 6 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007531 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007532 Size: 5 KB 網頁鏈接
Clene(CLNN):
Clene(CLNN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-007505 Size: 5 KB 網頁鏈接